Li Jian, Wang Jian-an
Cardiology Department of Pu Nan Hospital, Pudong New District, Shanghai 200125, China. lj.zj @126.com
J Zhejiang Univ Sci B. 2005 Apr;6(4):249-53. doi: 10.1631/jzus.2005.B0249.
Although after pacing animal and human studies have demonstrated a rate-dependent effect of sotalol on ventricular repolarization, there is little information on the effects of sotalol on ventricular repolarization during exercise. This study attempted to show the effects of sotalol on ventricular repolarization during physiological exercise.
Thirty-one healthy volunteers (18 males, 13 females) were enrolled in the study. Each performed a maximal treadmill exercise test according to the Bruce protocol after random treatment with sotalol, propranolol and placebo.
Sotalol significantly prolonged QTc (corrected QT) and JTc (corrected JT) intervals at rest compared with propranolol (QTc 324.86 ms vs 305.21 ms, P<0.001; JTc 245.04 ms vs 224.17 ms, P<0.001) and placebo (QTc 324.86 ms vs 314.06 ms, P<0.01; JTc 245.04 ms vs. 232.69 ms, P<0.001). The JTc percent reduction increased progressively with each stage of exercise and correlated positively with exercise heart rate (r=0.148, P<0.01). The JTc percent reduction correlation with exercise heart rate did not exist with either propranolol or placebo.
These results imply that with sotalol ventricular repolarization is progressively shortened after exercise. Thus the specific class III antiarrhythmic activity of sotalol, present as delay of ventricular repolarization, may be attenuated during exercise. Such findings may imply the need to consider other antiarrythmic therapy during periods of stress-induced tachycardia.
尽管在动物起搏和人体研究中已证明索他洛尔对心室复极有心率依赖性作用,但关于索他洛尔在运动期间对心室复极的影响的信息却很少。本研究试图展示索他洛尔在生理性运动期间对心室复极的影响。
31名健康志愿者(18名男性,13名女性)参与了本研究。在随机接受索他洛尔、普萘洛尔和安慰剂治疗后,每个人都按照布鲁斯方案进行了最大运动平板试验。
与普萘洛尔相比,索他洛尔在静息时显著延长了QTc(校正QT)和JTc(校正JT)间期(QTc:324.86毫秒对305.21毫秒,P<0.001;JTc:245.04毫秒对224.17毫秒,P<0.001),与安慰剂相比也显著延长(QTc:324.86毫秒对314.06毫秒,P<0.01;JTc:245.04毫秒对232.69毫秒,P<0.001)。JTc缩短百分比随着运动的每个阶段逐渐增加,并且与运动心率呈正相关(r = 0.148,P<0.01)。普萘洛尔或安慰剂与运动心率之间不存在JTc缩短百分比相关性。
这些结果表明,使用索他洛尔时,运动后心室复极会逐渐缩短。因此,索他洛尔作为III类抗心律失常药物的特异性活性,表现为心室复极延迟,在运动期间可能会减弱。这些发现可能意味着在应激性心动过速期间需要考虑其他抗心律失常治疗。